New Clinical Study Supports the Use of NeuraLight's Oculomet

New Clinical Study Supports the Use of NeuraLight's Oculometric Platform as a Viable Adjunct Assessment Tool in ALS

New Clinical Study Supports the Use of NeuraLight's Oculometric Platform as a Viable Adjunct Assessment Tool in ALS
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Tel Aviv , Israel , Texas , United States , Viviane Drory , , Tel Aviv University Sackler School Of Medicine , Flatiron Health , New Clinical Study Supports , Oculometric Platform , Viable Adjunct Assessment Tool , Amyotrophic Lateral Sclerosis , Frontotemporal Degeneration , Neuromuscular Diseases Unit , Tel Aviv Sourasky Medical Center , Tel Aviv University , Sackler School , Oculometric Measures , Clinical Assessment , Scientific Advisory Board , Pals , Eurology , Clinical Trials , Biotech , Precision Medicine , Results , Linical , Study , Published , Peer Reviewed , Journal , Amyotrophic , Bilateral , Clerosis , Frontotemporal , Regeneration , Tse , Neuralight , Software Based , Platform , Ls , Drug , Trial , Correlation , Culometric , Data , Gold Standard , Assessment , Scale , Patients , Lsfrs R , Bed , World Renowned , Researcher , Prof , Ivian , Rory , Director , Neuromuscular , Diseases , Unit , Department , Neurol , Ebwire , Press Release , Ews Release ,